| ABSTRACT:
In 2001, the Age-Related Eye Disease Study (AREDS), a US National Institute of Health, National Eye Institute clinical trial followed over 3000age-related macular degeneration (AMD) patients for 6.3 years. Scientists reported that progression to advanced AMD was delayed in patients with intermediate (Category 3) or advanced (Category 4) disease who received high doses of antioxidants (vitamin C, vitamin E, and beta carotene) plus zinc. This article suggests prescribing this dietary ocular supplement for delaying progression in advanced AMD patients, based on the established science of AREDS. |
Author(s):
Stuart P. Richer, OD, PhD, FAAO
Company: Mediconcepts, Inc
Expire Date: 08/01/2006
CE Credits: 1
Price: $20.00
CE Format: PDF
COPE ID: 9749-PS
|